Merck & Co. (MRK) Stock Price & AI Analysis

NASDAQ
USA

$103.09

-$1.20
(-1.52%)

Subscribe to get
AI Score

Merck & Co. Company Profile

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co. | Latest news

Understanding the Recent Fluctuations of Merck & Co Inc’s

The stock of Merck & Co Inc (MRK) has gone up by 1.43% for the week, with a 2.34% rise in the past month and a -10.67% drop in the past quarter. The volatility ratio for the week is 1.64%, and ...

NewsHeater - 3 hours ago

Why Merck & Co. (MRK) Is the Best Beginner Stock to Invest in Now?

We recently published a list of 11 Best Beginner Stocks To Invest In Now. In this article, we are...

Insider Monkey - 5 hours ago

Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It

Merck (MRK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise...

Zacks - 4 days ago

Merck (NYSE:MRK) Will Pay A Larger Dividend Than Last Year At $0.81

Merck & Co., Inc. (NYSE:MRK) will increase its dividend from last year's comparable payment on the...

Simply Wall St - 4 days ago

Merck Receives FDA Breakthrough Therapy Designation for Investigational Lung...

Merck (MRK, Financials) stated that sacituzumab tirumotecan (sac-TMT) was designated a Breakthrough...

GuruFocuscom - 6 days ago

Why Merck & Co. (MRK) Is Among the Best Affordable Stocks to Buy Right Now

We recently published a list of 12 Best Affordable Stocks To Buy Right Now. In this article, we are...

Insider Monkey - 3 days ago

Here’s What is Powering Merck & Co.’s (MRK) Earnings Growth

GreensKeeper Asset Management, an investment management company, released its third quarter investor...

Insider Monkey - 4 days ago

Why Is Merck & Co., Inc. (MRK) Among the Stocks Ray Dalio’s Bridgewater Is Crazy...

We recently compiled a list of the Billionaire Ray Dalio’s Bridgewater Is Crazy About These 15...

Insider Monkey - 7 days ago

Merck's ADC Drug Gets FDA Breakthrough Therapy Tag in NSCLC

Merck MRK announced that the FDA has granted breakthrough therapy designation (BTD) to sacituzumab...

Zacks - 5 days ago

Analysts Set Merck & Co., Inc. (NYSE:MRK) Price Target at $130.86

Shares of Merck & Co., Inc. (NYSE:MRK – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the nineteen brokerages that are presently covering the stock, Marketbeat.com ...

ETF DAILY NEWS - 6 days ago